https://www.zacks.com/commentary/2210113/top-analyst-reports-for-amd-abbott-laboratories-qualcomm?cid=CS-ZC-FT-research_daily-2210113
Jan 15, 2024 - Today's Research Daily features new research reports on 16 major stocks, including Advanced Micro Devices, Inc. (AMD), Abbott Laboratories (ABT) and QUALCOMM Incorporated (QCOM).
zc:-1817659563308448020
0
https://www.zacks.com/stock/news/2211543/abbott-s-abt-innovations-aid-macroeconomic-issues-stay?cid=CS-ZC-FT-analyst_blog|zer_report_update-2211543
Jan 17, 2024 - Abbott (ABT) is successfully continuing the rollout of Alinity, the company's fully integrated and automated molecular diagnostics analyzer.
zc:-5149813611187914168
0
https://www.zacks.com/stock/news/2212321/will-abbott-abt-beat-estimates-again-in-its-next-earnings-report?cid=CS-ZC-FT-tale_of_the_tape|yseop_template_7-2212321
Jan 18, 2024 - Abbott (ABT) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.
zc:-5656202813744707171
0
https://www.zacks.com/commentary/2219543/top-research-reports-for-abbott-t-mobile-booking?cid=CS-ZC-FT-research_daily-2219543
Feb 01, 2024 - Today's Research Daily features new research reports on 16 major stocks, including Abbott Laboratories (ABT), T-Mobile US, Inc. (TMUS) Booking Holdings Inc. (BKNG).
zc:-2929895383254301058
0
https://www.zacks.com/stock/news/2221954/hae-vs-abt-which-stock-is-the-better-value-option?cid=CS-ZC-FT-tale_of_the_tape|yseop_template_3-2221954
Feb 06, 2024 - HAE vs. ABT: Which Stock Is the Better Value Option?
zc:5368276042455414892
0
https://www.zacks.com/stock/news/2245409/abbott-abt-expands-in-canada-with-first-eterna-scs-use?cid=CS-ZC-FT-analyst_blog|company_news_-_medical_sector-2245409
Mar 25, 2024 - Abbott's (ABT) Eterna SCS system reduces pain without causing discomfort. It leverages the BurstDR stimulation technology.
zc:-3941071567344564522
0
https://www.zacks.com/stock/news/2251992/abbott-abt-faces-low-testing-demand-currency-headwinds?cid=CS-ZC-FT-analyst_blog|zer_report_update-2251992
Apr 08, 2024 - Abbott's (ABT) core laboratory diagnostics business is gaining strength on the continued success of the Alinity suite of diagnostics instruments, along with a broad test menu offering.
zc:8036270438900298026
0
https://www.zacks.com/stock/news/2252958/abbott-abt-rises-higher-than-market-key-facts?cid=CS-ZC-FT-tale_of_the_tape|yseop_template_6v1-2252958
Apr 09, 2024 - The latest trading day saw Abbott (ABT) settling at $112.44, representing a +1.74% change from its previous close.
zc:-3162060159274947691
0
https://www.zacks.com/stock/news/2256957/abbott-abt-q1-earnings-beat-estimates-margins-contract?cid=CS-ZC-FT-analyst_blog|earnings_article-2256957
Apr 17, 2024 - Abbott (ABT) delivers double-digit organic sales growth in its underlying base business in the first quarter of 2024.
zc:3308612154215796352
0